Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor empagliflozin directly increases keto... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
The SGLT2 inhibitor empagliflozin directly increases ketone utilisation in ischaemic hearts independent of substrate supply
0
Authors
Dylan Chase
3 more
Dylan Chase
•
Thomas Eykyn
1 more
•
Yu Chung
Published
November 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Molecular and Cellular Cardiology Plus
Topics
Biology
Ecology
Chemistry
Medicine
Biochemistry
Show all topics
DOI
10.1016/j.jmccpl.2024.100117
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Journal of Molecular and Cellular Cardiology Plus
Topics
Biology
Ecology
Chemistry
Medicine
Biochemistry
Show all topics
DOI
10.1016/j.jmccpl.2024.100117
License
CC-BY-NC-ND
